E3 ligase Ligand-Linker Conjugates 12
|
- $549 - $634.5
- Product name: E3 ligase Ligand-Linker Conjugates 12
- CAS: 1797406-80-4
- MF: C30H43N7O7S
- MW: 645.78
- EINECS:
- MDL Number:MFCD31807299
- Synonyms:E3 ligase Ligand-Linker Conjugates 12;(S,R,S)-AHPC-PEG3-azide;VH032-PEG3-N3;VHL Ligand-Linker Conjugates 8;(S,R,S) AHPC PEG3 N3,(S,R,S)-AHPC-PEG-3-N3,Inhibitor,inhibit,E3 Ligase Ligand-Linker Conjugates,(S,R,S)AHPCPEG3N3;(2S,4R)-1-((S)-14-azido-2-(tert-butyl)-4-oxo-6,9,12-trioxa-3-azatetradecanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide, Crosslinker?E3 Ligase ligand conjugate, Protein degrader building block for PROTAC? research, Template for synthesis of targeted protein degrader, VH032 conjugate;(S,R,S)-AHPC-PEG?-azide
2 prices
Selected condition：
Brand
- Iris Biotech GmbH
- Sigma-Aldrich
Package
- 50mg
- ManufacturerIris Biotech GmbH
- Product numberPTC1610
- Product description(S,R,S)-AHPC-PEG3-N3
- Packaging50mg
- Price$634.5
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product number904651
- Product description(S,R,S)-AHPC-PEG3-azide ≥95%
- Packaging50mg
- Price$549
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Iris Biotech GmbH | PTC1610 | (S,R,S)-AHPC-PEG3-N3 | 50mg | $634.5 | 2021-12-16 | Buy |
| Sigma-Aldrich | 904651 | (S,R,S)-AHPC-PEG3-azide ≥95% | 50mg | $549 | 2024-03-01 | Buy |
Properties
storage temp. :2-8°C
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
Description
Protein degrader builiding block (S,R,S)-AHPC-PEG3-Azide enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology. This conjugate contains a von Hippel-Lindau (VHL)-recruiting ligand and a PEGylated crosslinker with pendant azide for click chemistry with a target ligand. Because even slight alterations in ligands and crosslinkers can affect ternary complex formation between the target, E3 ligase, and PROTAC, many analogs are prepared to screen for optimal target degradation. When used with other protein degrader building blocks with a pendant azide group, parallel synthesis can be used to more quickly generate PROTAC libraries that feature variation in crosslinker length, composition, and E3 ligase ligand.Suppliers and manufacturers
TargetMol Chemicals Inc.
Aladdin Scientific
Sigma-Aldrich
Shanghai Chaolan Chemical Technology Center
Xi'an Confluore Biological Technology Co., Ltd.
Jilin Province Woda Biotechnology Co., Ltd.
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Shanghai Kaiwei Chemical Technology Co., Ltd.
Shanghai hongqu biomedical technology co. LTD
